Aducanumab and the FDA — where are we now?
Howard Fillit, Allan Green
Topics & Concepts
MedicineDrug approvalFood and drug administrationAdvisory committeeAlternative medicineDiseaseFamily medicineMEDLINEDrugIntensive care medicinePharmacologyPathologyLawPublic administrationPolitical scienceAlzheimer's disease research and treatmentsStatistical Methods in Clinical Trials